Gelesis

Boston, MA · CIK 0001385374 · Medtech · Defunct

Non-systemic superabsorbent hydrogels for weight management and GI disease

gelesis.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$38M
3 Form D · Dec 2015
129 months since last filing
Contracts
—
No federal contracts on record
Patents
40
13 granted · 27 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,638,696
Private capital raisedForm D · SEC$2,555,000
Private capital raisedForm D · SEC$31,499,980
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
860Harland Medical Systems, Inc.—$6.3M
861THERALASE TECHNOLOGIES INC /FI—$728K
862SOLTA MEDICAL INC—$47M
863Gelesis—$38M
864FUSmobile——
865Afraxis, Inc.—$2.9M
866ORTHOBOND CORPORATION—$12M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Mendy AxelradDirector
  • Elon BomsDirector
  • Eric ElenkoDirector
  • Meghan FitzgeraldDirector
  • Robert ForresterDirector
  • Rishi GuptaDirector
  • John LamattinaDirector
  • John LaMattinaDirector
  • Elliot MaltzExecutive Officer
  • Yishai ZoharDirector · Executive Officer

Patents

USPTO · 13 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.